The relative benefits of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) continue to be actively debated and analyzed. A recent meta-analysis of individual data from 7,812 patients in 10 randomized trials suggests that CABG may be associated with lower mortality in certain populations (level 2 [mid-level] evidence). There was no difference in overall mortality comparing CABG vs. PCI (15% vs. 16%), but mortality was significantly lower for CABG among 1,233 patients with diabetes (23% vs. 29%, p < 0.05, NNT 17) and among 2,688 patients ≥ 65 years old (20% vs. 24%, p < 0.05, NNT 25). There were no differences in mortality among younger patient populations. CABG was also associated with lower rates of angina at 1 year and repeat revascularization (Lancet 2009 Apr 4;373(9670):1190). All trials used either balloon angioplasty or bare-metal stents for PCI. For more information, see the Percutaneous coronary intervention vs. coronary artery bypass grafting topic in DynaMed.